- Home
- IVDA vs ICU Comparison
IVDA vs ICU Comparison
Compare IVDA & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVDA | ICU |
|---|---|---|
| Founded | 2003 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2M | 15.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IVDA | ICU |
|---|---|---|
| Price | $0.95 | $0.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 9.2M | 3.2M |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,395,926.00 | $881,000.00 |
| Revenue This Year | $340.48 | $691.85 |
| Revenue Next Year | N/A | $64.17 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 20.56 | ★ 1195.59 |
| 52 Week Low | $0.61 | $0.23 |
| 52 Week High | $8.05 | $3.07 |
Technical Indicators
Market Signals| Indicator | IVDA | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 45.11 | 31.89 |
| Support Level | $0.86 | $0.23 |
| Resistance Level | $1.04 | $0.36 |
| Average True Range (ATR) | 0.12 | 0.03 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 15.09 | 19.62 |
Price Performance
Historical ComparisonAbout IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.